Literature DB >> 25761971

Erratum to: TDP-43 Proteinopathy and ALS: Insights into Disease Mechanisms and Therapeutic Targets.

Emma L Scotter1, Han-Jou Chen, Christopher E Shaw.   

Abstract

Entities:  

Year:  2015        PMID： 25761971      PMCID： PMC4404465          DOI： 10.1007/s13311-015-0351-0

Source DB:  PubMed          Journal:  Neurotherapeutics        ISSN： 1878-7479            Impact factor:   7.620


× No keyword cloud information.
  6 in total

Review 1.  Autophagy Dysregulation in ALS: When Protein Aggregates Get Out of Hand.

Authors:  Nandini Ramesh; Udai Bhan Pandey
Journal:  Front Mol Neurosci       Date:  2017-08-22       Impact factor: 5.639

Review 2.  An insight into the iPSCs-derived two-dimensional culture and three-dimensional organoid models for neurodegenerative disorders.

Authors:  Anushka Bhargava; Ana M Sandoval Castellanos; Sonali Shah; Ke Ning
Journal:  Interface Focus       Date:  2022-08-12       Impact factor: 4.661

3.  The D2 Dopamine Receptor Interferes With the Protective Effect of the A2A Adenosine Receptor on TDP-43 Mislocalization in Experimental Models of Motor Neuron Degeneration.

Authors:  Chia-You Lai; Yu-Ju Liu; Hsing-Lin Lai; Hui-Mei Chen; Hung-Chi Kuo; Yu-Ping Liao; Yijuang Chern
Journal:  Front Neurosci       Date:  2018-03-20       Impact factor: 4.677

Review 4.  The genetics of amyotrophic lateral sclerosis: current insights.

Authors:  Afnan A Alsultan; Rachel Waller; Paul R Heath; Janine Kirby
Journal:  Degener Neurol Neuromuscul Dis       Date:  2016-05-13

5.  A robust TDP-43 knock-in mouse model of ALS.

Authors:  Shih-Ling Huang; Lien-Szu Wu; Min Lee; Chin-Wen Chang; Wei-Cheng Cheng; Yu-Sheng Fang; Yun-Ru Chen; Pei-Lin Cheng; Che-Kun James Shen
Journal:  Acta Neuropathol Commun       Date:  2020-01-21       Impact factor: 7.801

Review 6.  The role of TDP-43 propagation in neurodegenerative diseases: integrating insights from clinical and experimental studies.

Authors:  Myungjin Jo; Shinrye Lee; Yu-Mi Jeon; Seyeon Kim; Younghwi Kwon; Hyung-Jun Kim
Journal:  Exp Mol Med       Date:  2020-10-13       Impact factor: 8.718
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.